We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+42.53%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.29B
AUM Growth
+$566M
Cap. Flow
-$11.7M
Cap. Flow %
-0.51%
Top 10 Hldgs %
20.65%
Holding
346
New
133
Increased
78
Reduced
97
Closed
28

Top Sells

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$37.3M
2
TREX icon
Trex
TREX
+$22.9M
3
CHGG icon
Chegg
CHGG
+$20.7M
4
TDOC icon
Teladoc Health
TDOC
+$19.2M
5
HAE icon
Haemonetics
HAE
+$18.8M

Sector Composition

Rank Sector Weight
1 Healthcare 23.18%
2 Industrials 15.21%
3 Technology 14.54%
4 Consumer Discretionary 13.91%
5 Consumer Staples 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PS
26
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$26.2M 1.14%
1,453,711
+82,812
+6% +$1.4M
SAM icon
27
Boston Beer
SAM
$1.86B
$25.7M 1.12%
47,819
-4,668
-9% -$2.26M
ITGR icon
28
Integer Holdings
ITGR
$3.24B
$25.1M 1.09%
343,704
-28,103
-8% -$2.04M
TRHC
29
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$24.3M 1.06%
444,119
+16,061
+4% +$919K
SAIC icon
30
Saic
SAIC
$4.88B
$24M 1.05%
309,315
+49,122
+19% +$4.03M
UTHR icon
31
United Therapeutics
UTHR
$22.7B
$24M 1.04%
198,161
+68,104
+52% +$7.66M
PPBI
32
DELISTED
Pacific Premier Bancorp
PPBI
$23.8M 1.04%
1,099,161
-3,671
-0.3% -$73.6K
TMHC icon
33
Taylor Morrison
TMHC
$6.64B
$23.8M 1.04%
1,233,796
+516,305
+72% +$8.13M
BLD
34
DELISTED
TopBuild
BLD
$23.6M 1.03%
207,478
+73,074
+54% +$7.3M
KPTI icon
35
Karyopharm Therapeutics
KPTI
$216M
$23.6M 1.03%
82,947
+13,244
+19% +$3.92M
ATRC icon
36
AtriCure
ATRC
$1.77B
$23.5M 1.02%
522,273
+95,661
+22% +$4.16M
TNET icon
37
TriNet
TNET
$2.74B
$23.2M 1.01%
381,133
+90,854
+31% +$4.54M
CCXI
38
DELISTED
ChemoCentryx, Inc.
CCXI
$23.1M 1.01%
401,839
+27,105
+7% +$1.48M
EYE icon
39
National Vision
EYE
$1.66B
$22.3M 0.97%
732,250
+555,410
+314% +$14.6M
VIAV icon
40
Viavi Solutions
VIAV
$9.41B
$22.2M 0.97%
1,738,905
-2,498
-0.1% -$30K
MRTX
41
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$21.6M 0.94%
189,243
-37,656
-17% -$3.65M
BWIN
42
Baldwin Insurance Group
BWIN
$2.66B
$21.3M 0.93%
1,232,854
+424,566
+53% +$5.12M
FIVE icon
43
Five Below
FIVE
$11.2B
$21.2M 0.92%
198,464
-915
-0.5% -$85.8K
REPL icon
44
Replimune Group
REPL
$859M
$21.2M 0.92%
852,503
+56,903
+7% +$1.01M
TWST icon
45
Twist Bioscience
TWST
$5.84B
$21M 0.92%
464,250
-29,226
-6% -$1.05M
MC icon
46
Moelis & Co
MC
$5.02B
$20.9M 0.91%
671,214
+12,368
+2% +$388K
GTLS icon
47
Chart Industries
GTLS
$20.3M 0.89%
419,188
+73,127
+21% +$2.68M
ADUS icon
48
Addus HomeCare
ADUS
$2.14B
$19.4M 0.85%
209,809
-640
-0.3% -$55.4K
ALRM icon
49
Alarm.com
ALRM
$2.63B
$19M 0.83%
293,701
-6,460
-2% -$325K
AJRD
50
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$18.6M 0.81%
469,902
-2,926
-0.6% -$122K

Similar funds

Emerald Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Emerald Advisers held 346 positions worth $2.29B, up 33% from $1.73B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Emerald Advisers's Q2 2020 filing shows 133 new, 78 increased, 97 reduced and 28 closed positions. Its largest new stake was Installed Building Products: 260,330 shares worth $17.9M. The largest sale was Ciena, an estimated $37.3M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Industrials and Technology.

  • Emerald Advisers's largest Q2 2020 buy was Installed Building Products: 260,330 shares worth $17.9M.
  • Emerald Advisers added most to National Vision in Q2 2020, an estimated $14.6M increase.
  • Emerald Advisers's biggest Q2 2020 reduction was Ciena, cutting an estimated $37.3M.
  • Emerald Advisers fully exited Teladoc Health in Q2 2020, selling an estimated $19.2M.
  • Emerald Advisers's ten largest holdings make up 21% of its $2.29B portfolio in Q2 2020.
  • Emerald Advisers opened 133 new positions and closed 28 in Q2 2020.
  • Emerald Advisers's portfolio value rose 33% quarter-over-quarter to $2.29B.

Based on Emerald Advisers's 13F filing for Q2 2020, filed 28 Jul 2020.